Fact CheckerSign in

NCT06751030Active, not recruiting

Community, Home-based Education, Screening Services Strategy to Increase Cervical Cancer Control Access for HIV-Positive Women in Nigeria

Community, Home-based Education, Screening Services (CHESS) Strategy to Increase Cervical Cancer Control Access for HIV-Positive Women in Nigeria

Source: ClinicalTrials.gov · Last updated 4 Nov 2026

Brief summary (registry, in English)

The goal of this observational study is to focus on adapting and implementing a program to promote HPV and cervical cancer (CC) screening and follow-up treatment for HIV-positive women, with three specific aims: * Adaptation: Use stakeholder deliberation to tailor the successful MoMent program for this population. * Implementation and Assessment: Deploy the adapted MoMent program and evaluate its reach, effectiveness, adoption, and fidelity. * Evaluation: Conduct a post-implementation process evaluation to identify barriers and facilitators to the program's maintenance and sustainability.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
1500 (estimated)
First submitted
20 Dec 2024
Start date
3 Dec 2024
Primary completion date
Aug 2028
Lead sponsor
Emory University
NCT number
NCT06751030

What you commit to

  • Study type: Observational
  • Planned participants: 1500
  • From 3 Dec 2024 to the primary completion date, Aug 2028
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Unknown or negative HIV status

Age

  • Age \<25 or \>50

Other

  • Male gender
  • Pregnancy
  • Hysterectomy
  • Inability to give informed consent Inability/refusal to perform vaginal self-collection

Who the study is looking for

  • \- Patients must be able to perform vaginal self-collection as well as give informed consent

Age in the registry: 25 years to 50 years · Sex: Female

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
APIN Health Initiatives
Coordinator of this site? Confirm its status
AbujaNigeriaUnknown status
University of Ibadan
Coordinator of this site? Confirm its status
IbadanNigeriaUnknown status
Nigeria Institute of Medical Research (NIMR
Coordinator of this site? Confirm its status
LagosNigeriaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.